Ozempic – Type 2 Diabetes – Novo Ozempic GM APR Display Banners HCP Wallboard Extension 2023 – 53875

Obesity Medicine Opens 2023 With Important Advances

Announcements from the AMA and the AAP, plus innovative drug launches, are some of the major developments in Obesity Medicine. The year has opened with many important new milestones in obesity medicine. Healthcare professionals...

Read More

Pioglitazone Linked to Reduced Dementia Risk in T2D

For patients with diabetes mellitus (DM), pioglitazone use is associated with a reduced risk for dementia, especially in those with a history of ischemic heart disease or stroke, according to a study published in Neurology....

Read More

For latest news and updates
Email-id is invalid